J Infect Dis:基因检测打开未来个体化根除幽门螺杆菌之门

2013-10-14 佚名 丁香园

2013年10月刊发在J Infect Dis杂志上的一项最新研究显示,幽门螺杆菌(H.pylori)23S核糖体RNA基因的点突变测试阳性患者应用特定疗法可使H.pylori清除率显著高于标准三联疗法。 随着幽门螺旋杆菌耐药率上升,标准的三联疗法已经受到挑战。此前证实克拉霉素耐药的幽门螺杆菌与23S核糖体RNA(rRNA)基因的点突变相关。【原文下载】 为了确定基因检测对个体化疗法根除H.p

2013年10月刊发在J Infect Dis杂志上的一项最新研究显示,幽门螺杆菌(H.pylori)23S核糖体RNA基因的点突变测试阳性患者应用特定疗法可使H.pylori清除率显著高于标准三联疗法。

随着幽门螺旋杆菌耐药率上升,标准的三联疗法已经受到挑战。此前证实克拉霉素耐药的幽门螺杆菌与23S核糖体RNA(rRNA)基因的点突变相关。【原文下载

为了确定基因检测对个体化疗法根除H.pylori的作用,来自韩国的研究者对超过1200例的患者进行了相关试验研究,受试者被分成2个对照组和1个病例组。随机分配的308例受试者组成的APC对照组的患者使用阿莫西林、雷贝拉唑和克拉霉素的标准三联疗法;APM对照组的308例患者使用阿莫西林、雷贝拉唑和甲硝唑。对病例组的616例受试者进行幽门螺杆菌的23S核糖体RNA基因的点突变测试。其中病例组有218例个体患者接受特定的治疗方案,即在无变异的情况下,使用阿莫西林、雷贝拉唑和克拉霉素,如果检测到变异,克拉霉素将被甲硝唑代替。

结果显示,接受特定的治疗方案组的的幽门螺杆菌清除率为91.2%(176/193),显著高于APC对照组(75.9% [214/282];P<0.001)和APM对照组(79.1% [219/277];P<0.001)。

研究者最后总结,通过聚合酶链反应检出克拉霉素耐药变异的H.pylori感染患者并给予特定治疗方案可取得较高的根除率,基因检测或可为未来提供个体化根除幽门杆菌治疗提供基础,不过对其成本效益仍需进行更进一步的研究。

原文检索

Lee HJ, Kim JI, Cheung DY, Kim TH, Jun EJ, Oh JH, Chung WC, Kim BW, Kim SS, Park SH, Kim JK.Eradication of Helicobacter pylori According to 23S Ribosomal RNA Point Mutations Associated With Clarithromycin Resistance.J Infect Dis. 2013 Oct;208(7):1123-30.【原文下载

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1811676, encodeId=40ea18116e6cf, content=<a href='/topic/show?id=751f8889423' target=_blank style='color:#2F92EE;'>#螺杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88894, encryptionId=751f8889423, topicName=螺杆菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Fri Apr 18 00:30:00 CST 2014, time=2014-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683619, encodeId=b79c16836191c, content=<a href='/topic/show?id=c2fc6228167' target=_blank style='color:#2F92EE;'>#根除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62281, encryptionId=c2fc6228167, topicName=根除)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Wed Dec 25 06:30:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011857, encodeId=d9e7201185e91, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Tue Mar 04 03:30:00 CST 2014, time=2014-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435262, encodeId=2c931435262cb, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21278, encryptionId=9a5c212e88f, topicName=个体化)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Oct 16 01:30:00 CST 2013, time=2013-10-16, status=1, ipAttribution=)]
    2014-04-18 kcb069
  2. [GetPortalCommentsPageByObjectIdResponse(id=1811676, encodeId=40ea18116e6cf, content=<a href='/topic/show?id=751f8889423' target=_blank style='color:#2F92EE;'>#螺杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88894, encryptionId=751f8889423, topicName=螺杆菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Fri Apr 18 00:30:00 CST 2014, time=2014-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683619, encodeId=b79c16836191c, content=<a href='/topic/show?id=c2fc6228167' target=_blank style='color:#2F92EE;'>#根除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62281, encryptionId=c2fc6228167, topicName=根除)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Wed Dec 25 06:30:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011857, encodeId=d9e7201185e91, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Tue Mar 04 03:30:00 CST 2014, time=2014-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435262, encodeId=2c931435262cb, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21278, encryptionId=9a5c212e88f, topicName=个体化)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Oct 16 01:30:00 CST 2013, time=2013-10-16, status=1, ipAttribution=)]
    2013-12-25 docwu2019
  3. [GetPortalCommentsPageByObjectIdResponse(id=1811676, encodeId=40ea18116e6cf, content=<a href='/topic/show?id=751f8889423' target=_blank style='color:#2F92EE;'>#螺杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88894, encryptionId=751f8889423, topicName=螺杆菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Fri Apr 18 00:30:00 CST 2014, time=2014-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683619, encodeId=b79c16836191c, content=<a href='/topic/show?id=c2fc6228167' target=_blank style='color:#2F92EE;'>#根除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62281, encryptionId=c2fc6228167, topicName=根除)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Wed Dec 25 06:30:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011857, encodeId=d9e7201185e91, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Tue Mar 04 03:30:00 CST 2014, time=2014-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435262, encodeId=2c931435262cb, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21278, encryptionId=9a5c212e88f, topicName=个体化)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Oct 16 01:30:00 CST 2013, time=2013-10-16, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1811676, encodeId=40ea18116e6cf, content=<a href='/topic/show?id=751f8889423' target=_blank style='color:#2F92EE;'>#螺杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88894, encryptionId=751f8889423, topicName=螺杆菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Fri Apr 18 00:30:00 CST 2014, time=2014-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683619, encodeId=b79c16836191c, content=<a href='/topic/show?id=c2fc6228167' target=_blank style='color:#2F92EE;'>#根除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62281, encryptionId=c2fc6228167, topicName=根除)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Wed Dec 25 06:30:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011857, encodeId=d9e7201185e91, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Tue Mar 04 03:30:00 CST 2014, time=2014-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435262, encodeId=2c931435262cb, content=<a href='/topic/show?id=9a5c212e88f' target=_blank style='color:#2F92EE;'>#个体化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21278, encryptionId=9a5c212e88f, topicName=个体化)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Oct 16 01:30:00 CST 2013, time=2013-10-16, status=1, ipAttribution=)]

相关资讯

韩宝惠:肺癌驱动基因检测指导个体化治疗

肺癌是世界范围内恶性肿瘤中威胁人类健康的头号杀手,2009年美国肺癌和支气管癌的新发病例估计为219440例(男性116090例,女性103305例),死亡159306例(男性88900例,女性103350例)。据美国SEER统计数据显示,在肺癌确诊时,16%的患者肿瘤仍局限在原发部位,25%的患者肿瘤已扩展至区域淋巴结或直接侵犯周围组织,51%的患者已发生远处转移,其余8%的患者信息不明,只有1

基因检测:99美元/人份目标,可能挑战医学模式

    作为“量化自身”(Quantified Self)运动的主要赞助者,融合在线工具+社交网络+众包模式于一体的基因检测先驱 -23andMe  ,新融资5千万美元,其创始人 Anne Wojcicki (Google创始人的太太)宣布:100万用户,99美元的新目标!    如果这一目标实现,将极大推动个性化医疗的发展

遗传学决定糖尿病患者的治疗

对一些糖尿病患者来说,基因检测是唯一能获得准确诊断和确保有效治疗的方法。如果没有基因检测,很多年轻的单基因型糖尿病患者将永远得不到最恰当的治疗。 由于这些类型的糖尿病往往不典型,通常用于治疗1型与2型糖尿病的手段是无效的,不仅浪费资源,且有潜在的风险。 问题是这些病人没有标志性的语言说我“我是单基因糖尿病”,因此美国大约有90%的单基因糖尿病没有被诊断。医生必须能够辨认出那些有适当的临床特征的

基因检测确诊一例无症状的Wilson病

     2005年3月,我们收治了一位30岁无症状的e抗原阳性慢性乙型肝炎男子。其丙氨酸转氨酶(ALT)水平为182 U/L,乙型肝炎病毒(HBV)DNA的浓度为6.68×105 IU/mL,临床检查和其他化验结果无特殊。遂开始用当时唯一可用的核苷类药物—— 拉米夫定100 mg/d 进行治疗。18个月后检测上述两项指标仍偏高,加用阿德福韦10

乳癌诊治别忽视HER2基因检测

  近日,出席全国第三届乳腺癌论坛(南京)暨全国乳腺癌规范化综合诊治学习班的著名乳腺外科专家、江苏省肿瘤医院院长唐金海教授指出,乳腺癌患者一旦确诊应尽早进行HER2(人类表皮生长因子受体-2)基因检测,此举有助于识别乳腺癌的类型和状态,便于确定针对性强的治疗方案,延长相对应的乳腺癌患者生存时间。   据介绍,我国近年来的乳腺癌发病率持续升高,但是乳腺癌的死亡率已开始出现下降趋势,这与乳腺癌临床新